The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension
Changlei Bao(North West Agriculture and Forestry University), Haiyang Tang(First Affiliated Hospital of Guangzhou Medical University), Stephen M. Black(Florida International University), Jennifer S. Carew(University of Arizona), Zi Yang(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Jason X.‐J. Yuan(Scripps Research Institute), Shichuang Zheng(North West Agriculture and Forestry University), Shiyun Liu(North West Agriculture and Forestry University), Jian Wang(Guangzhou Experimental Station), Ting Wang(Jilin University), Yuzhu Li(Zhengzhou University), Yali Gu(Banner - University Medical Center Tucson), Yanan Sun(Zhengzhou University), Steffan T. Nawrocki(University of Arizona), Shuxin Liang(Jiangnan University), Kang Wu(Wuhan University), Ying Han(Ministry of Education)
Cited by 27
Related Papers
Characterization of ferroptosis in murine models of hemochromatosis
|Hepatology|2017|669
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Targeting HSP90 for cancer therapy
|British Journal of Cancer|2009|320